From Our Partners · Whitepaper
Cell and Gene Therapies 2018 – State Of The Industry Report
It is an exciting time to be involved in the cell and gene therapy industries. There are both opportunities and challenges around analytical testing, manufacturing, process automation, supply chain, regulations, and business deals to name but a few, often still with more questions than answers.
KNect365 Life Sciences conducted one of the biggest surveys of its kind across cell and gene therapy professionals from pharma, biotechs, academia, CDMOs, service providers, and regulators around the world. This final report based on 165 responses reveals unique insights into the state of the cell and gene therapy industries in 2018; the hottest potential opportunities; the biggest challenges; and how industry insiders are tackling them.
The report also features an introduction by Dan Stanton, editor of BioProcess Insider, exploring what some of the key takeaways mean for the industry.